Tiny stem cell companies close in on major heart disease goals 18 Dec, 2017
NEW YORK: The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell champion Geron Corp abandoning the field in 2011.But two small companies, Athersys Inc and Mesoblast Ltd, are ...